CO82 Dupilumab Is Effective in Patients with Atopic Dermatitis and Inadequate Response, Intolerance, or Contraindication to Cyclosporine: A Systematic Review and Meta-Analysis
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.156
https://www.valueinhealthjournal.com/article/S1098-3015(23)00256-5/fulltext
Title :
CO82 Dupilumab Is Effective in Patients with Atopic Dermatitis and Inadequate Response, Intolerance, or Contraindication to Cyclosporine: A Systematic Review and Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00256-5&doi=10.1016/j.jval.2023.03.156
First page :
Section Title :
Open access? :
No
Section Order :
10994